2026-525574-19-00招募中1 期
A Study of Long-Term Safety, Tolerability, and Clinical Outcomes of Intrathecally Administered LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis: A Multicenter, Open-Label, Long-Term Extension of Study J6I-MC-OWAA
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 16
- 试验地点
- 7
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
Lilly Clinical Trials information desk
Scientific
Eli Lilly & Co.
研究点 (7)
Loading locations...
相似试验
招募中
1 期
A study investigating the safety, tolerability, metabolism, and elimination of INE963, a new compound in the treatment of malaria.Malaria2024-516911-26-00Novartis Pharma AG94
已完成
1 期
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Zosurabalpin following Intravenous Administration in Healthy ParticipantsThere is no medical condition being investigated. This is a safety and pharmacokinetic study to be performed in healthy participants.2023-505411-20-00F. Hoffmann-La Roche AG, F. Hoffmann-La Roche AG30
招募中
1 期
A Study to Evaluate the Safety, Tolerability, and Activity of a Novel Oral Anticancer Drug (FLC‑436) in Patients With Refractory or Relapsed Solid MalignanciesRefractory or Relapsed Solid Malignancies2026-526215-10-00Fileclo Sp. z o.o.30
招募中
1 期
A STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF COR-1389Obesity / Right heart failure (healthy participants)2024-514853-31-00Corteria Pharmaceuticals80
暂停
1 期
A study to investigate the safety, tolerability, pharmacokinetics, immunogenicity and pharmacodynamics of a single subcutaneous dose of GSK4771261 in healthy participants aged 25 to 55 years of age inclusiveAutosomal Dominant Polycystic Kidney Disease2025-525073-37-00Glaxosmithkline Research & Development Limited30